Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Santyl Ointment for Diabetic Foot Wounds
NCT01408277Phase 4Completed
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Aug 2011
- Primary completion
- Nov 2012
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of collagenase clostridium histolyticum in diabetic foot ulcer (DFU), sponsored by Healthpoint Biotherapeutics. Started Aug 2011; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01408277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408277.